Research progress on anti-inflammatory therapy for ischemic stroke
10.3969/j.issn.1672-5921.2025.08.008
- VernacularTitle:缺血性卒中抗炎治疗的研究进展
- Author:
Kangmo HUANG
1
;
Yiting NING
1
;
Juan DU
1
;
Wusheng ZHU
1
Author Information
1. 210002 南京大学医学院附属金陵医院(东部战区总医院)神经内科
- Publication Type:Journal Article
- Keywords:
Ischemic stroke;
Inflammation;
Residual inflammatory risk;
Anti-inflammatory agents;
Secondary prevention
- From:
Chinese Journal of Cerebrovascular Diseases
2025;22(8):570-578
- CountryChina
- Language:Chinese
-
Abstract:
Ischemic stroke,a major public health challenge,is marked by high incidence,disability,and mortality rates.The pathophysiology of stroke is complex,and inflammation reaction plays a crucial role throughout the process.In recent years,anti-inflammatory treatment has become a major focus in researches of ischemic stroke.Current preclinical and clinical investigations have revealed the potential of various anti-inflammatory strategies for ischemic stroke.However,which patient populations benefit from existing drugs are not yet elucidated.Additionally,drugs targeting innate immune cascades have become a new research hot spot.This article reviewed the latest clinical advances in anti-inflammatory therapy for ischemic stroke and discusses its promising prospects,aiming to provide novel clinical application strategies and future research directions.
